In contrast, the ERβ forms heterodimers with the ERα blocking their proliferative activity by suppression of oncogenic transcription factors (e.g. c-myc, cyclin D1 e cyclin A) and by stimulating the expression of tumour suppressing genes (e.g. p21 e p27) [38]. The gene discussed is MYC; the disease is neoplasm.